Kelly Lawrence W & Associates’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
KA
Kelly Lawrence W & Associates's TDOC Position: Q4 2022 in Review
Kelly Lawrence W & Associates sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 10,800 shares — an estimated $274K sold.
Kelly Lawrence W & Associates first reported a position in TDOC in Q2 2022 and held it in 2 quarters. The position peaked at $359K in Q2 2022. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.
- Kelly Lawrence W & Associates reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
- Kelly Lawrence W & Associates sold 10,800 Teladoc Health shares in Q4 2022, an estimated $274K.
- Kelly Lawrence W & Associates first reported a position in Teladoc Health in Q2 2022 and held it in 2 quarters.
- Kelly Lawrence W & Associates's Teladoc Health position peaked at $359K in Q2 2022.
- 444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.
Based on Kelly Lawrence W & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.